Literature DB >> 8173772

Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis.

A Pesci1, G A Rossi, G Bertorelli, A Aufiero, P Zanon, D Olivieri.   

Abstract

In order to evaluate the degree of mast cell infiltration and determine their granulation state in the airways of patients with chronic bronchitis, bronchoscopy was performed in 25 chronic bronchitis subjects (10 smokers and 15 ex-smokers) with mucoid sputum production and in seven normal nonsmoking control subjects. Bronchoalveolar lavage and bronchial biopsies were examined using histochemical techniques. Subjects with chronic bronchitis had higher numbers of mast cells both in the epithelium (1.22 +/- 1 versus 0.22 +/- 0.2 mast cells per mm) and in the bronchial glands (137.4 +/- 37.9 versus 38 +/- 5.1 mast cells per mm2) than did control subjects (p < 0.01 and p < 0.001, respectively), whereas the numbers of mast cells in bronchoalveolar lavage (0.21 +/- 0.1 versus 0.18 +/- 0.1 mast cells percentage, nonsignificant [NS]) and in the lamina propria (87.5 +/- 66.4 versus 87.2 +/- 61.8 mast cells per mm2, NS) were similar in the two groups. In the smoking group of bronchitics an increase in mast cell numbers was observed in epithelium (1.6 +/- 1.3 versus 0.95 +/- 0.7 mast cells per mm, NS), in lamina propria (112.2 +/- 86.5 versus 71.7 +/- 45.7 mast cells per mm2), and in BAL (0.26 +/- 0.21 versus 0.16 +/- 0.17 mast cell percentage of total cells, NS) in comparison with the ex-smoker's group of bronchitics.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8173772     DOI: 10.1164/ajrccm.149.5.8173772

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

2.  Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers.

Authors:  D Miotto; M D Hollenberg; N W Bunnett; A Papi; F Braccioni; P Boschetto; F Rea; A Zuin; P Geppetti; M Saetta; P Maestrelli; L M Fabbri; C E Mapp
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

Review 3.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

4.  Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages.

Authors:  W F Grashoff; J K Sont; P J Sterk; P S Hiemstra; W I de Boer; J Stolk; J Han; J M van Krieken
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  Relation between duration of smoking cessation and bronchial inflammation in COPD.

Authors:  T S Lapperre; D S Postma; M M E Gosman; J B Snoeck-Stroband; N H T ten Hacken; P S Hiemstra; W Timens; P J Sterk; T Mauad
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

6.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

7.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma.

Authors:  N G Carroll; S Mutavdzic; A L James
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 8.  Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 9.  Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease.

Authors:  R Polosa; S Rorke; S T Holgate
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 10.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.